Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.31 |
| ▸ | FUCA1 | P04066 | 1/20 | 0.31 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.31 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.30 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.30 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | KDM5C | P41229 | 1/20 | 0.30 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.30 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.30 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.30 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9971593 | 0.98 | TERT (0.39) | TERTALDH1A1LMNAMCL1CA1 | |
| SCHEMBL210050 | 0.81 | — | — | |
| Hydrochloric Acid SCHEMBL9317289 | 0.78 | — | — | |
| Hydrochloric Acid SCHEMBL719172 | 0.78 | — | — | |
| SCHEMBL24261804 | 0.78 | TERT (0.39) | TERTLMNACA1CA2RECQL | |
| SCHEMBL17980508 | 0.78 | TERT (0.39) | TERTLMNACA1CA2RECQL | |
| SCHEMBL13660545 | 0.78 | MCL1 (0.41) | TERTALDH1A1LMNAMCL1CA1 | |
| SCHEMBL17874650 | 0.78 | MCL1 (0.41) | TERTALDH1A1LMNAMCL1CA1 | |
| SCHEMBL19985684 | 0.78 | MCL1 (0.41) | TERTALDH1A1LMNAMCL1CA1 | |
| SCHEMBL15700609 | 0.78 | TERT (0.39) | TERTLMNACA1CA2RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106636013-A | Ankara virus strain FAdV-HB and preparation and application of inactivated vaccine of ankara virus strain FAdV-HB | 华中农业大学 | 2017-05-10 | — | — | CN | claimed |
| US-12622975-B2 | Peptide-conjugated prodrugs | BRANDEIS UNIVERSITY (US) | 2026-05-12 | — | — | US | disclosed |
| WO-2023178641-A1 | DNA TOXIC DIMER COMPOUND AND CONJUGATE THEREOF | 成都百利多特生物药业有限责任公司 | 2023-09-28 | — | — | WO | disclosed |
| US-20220387610-A1 | PEPTIDE-CONJUGATED PRODRUGS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-12-08 | — | — | US | disclosed |
| EP-3812376-A1 | PACLITAXEL-LIPID-POLYSACCHARIDE DUAL-TYPE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF | Santolecan Pharmaceuticals LLC (US) | 2021-04-28 | — | — | EP | disclosed |
| US-20200376013-A1 | SELECTIVE DRUG DELIVERY COMPOSITIONS AND METHODS OF USE | AVELAS BIOSCIENCES, INC. | 2020-12-03 | — | — | US | disclosed |
| WO-2020234167-A1 | PRINTABLE HYDROGEL, METHOD FOR GENERATING A PRINTABLE HYDROGEL, LYOPHILIZATE, PRINTED PRODUCT AND 3D PRINTING METHOD | ETH Zürich (CH) | 2020-11-26 | — | — | WO | disclosed |
| US-20190076547-A1 | ANTIBODY ADJUVANT CONJUGATES | BOLT BIOTHERAPEUTICS, INC. | 2019-03-14 | — | — | US | disclosed |
| EP-2350120-B1 | MULTILIGAND CONSTRUCTS | SEMIOTIK LLC (RU) | 2017-10-11 | — | — | EP | disclosed |
| CN-106636013-A | Ankara virus strain FAdV-HB and preparation and application of inactivated vaccine of ankara virus strain FAdV-HB | 华中农业大学 | 2017-05-10 | — | — | CN | disclosed |
| US-20140024640-A1 | Benzazepine Derivatives Useful as Vasopressin Antagonists | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2014-01-23 | — | — | US | disclosed |
| US-20140024619-A1 | Benzazepine Derivatives Useful as Vasopressin Antagonists | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2014-01-23 | — | — | US | disclosed |
| EP-2374798-B1 | Benzazepine derivatives useful as vasopressin antagonists | OTSUKA PHARMA CO LTD (JP) | 2013-09-04 | — | — | EP | disclosed |
| EP-2170831-B1 | Benzazepine derivatives useful as vasopressin antagonists | OTSUKA PHARMA CO LTD (JP) | 2012-02-15 | — | — | EP | disclosed |
| EP-2374797-A1 | Benzazepine derivatives useful as vasopressin antagonists | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2011-10-12 | — | — | EP | disclosed |
| EP-2374798-A1 | Benzazepine derivatives useful as vasopressin antagonists | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2011-10-12 | — | — | EP | disclosed |
| US-20110071084-A1 | BENZAZEPINE DERIVATIVES USEFUL AS VASOPRESSIN ANTAGONISTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2011-03-24 | — | — | US | disclosed |
| EP-2170831-A1 | BENZAZEPINE DERIVATIVES USEFUL AS VASOPRESSIN ANTAGONISTS | Otsuka Pharmaceutical Co., Ltd. (JP) | 2010-04-07 | — | — | EP | disclosed |
| US-20100036111-A1 | METHOD FOR REPLICATING NUCLEIC ACIDS AND NOVEL UNNATURAL BASE PAIRS | RIKEN (JP) | 2010-02-11 | — | — | US | disclosed |
| WO-2009001968-A1 | BENZAZEPINE DERIVATIVES USEFUL AS VASOPRESSIN ANTAGONISTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2008-12-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12622975-B2 | Peptide-conjugated prodrugs | PEPD, PAM, VIP | TERT 4841/4885ALDH1A1 3596/4885LMNA 1538/4885 |
| US-20220387610-A1 | PEPTIDE-CONJUGATED PRODRUGS | VIP, DNPEP, PEPD | TERT 4603/4885ALDH1A1 4110/4885LMNA 3184/4885 |
| US-20100036111-A1 | METHOD FOR REPLICATING NUCLEIC ACIDS AND NOVEL UNNATURAL BASE PAIRS | POLM, POLL, POLRMT | TERT 579/4885ALDH1A1 2586/4885LMNA 3624/4885 |
| US-20200376013-A1 | SELECTIVE DRUG DELIVERY COMPOSITIONS AND METHODS OF USE | ABCG2, CD44, PITRM1 | TERT 4860/4885ALDH1A1 3790/4885LMNA 443/4885 |
| US-20190076547-A1 | ANTIBODY ADJUVANT CONJUGATES | FCGR1A, FCGR3B, FCGR2A | TERT 1356/4885ALDH1A1 954/4885LMNA 4851/4885 |
| US-20110071084-A1 | BENZAZEPINE DERIVATIVES USEFUL AS VASOPRESSIN ANTAGONISTS | AVPR2, AVPR1B, AVPR1A | TERT 3784/4885ALDH1A1 1456/4885LMNA 2356/4885 |
| US-20140024619-A1 | Benzazepine Derivatives Useful as Vasopressin Antagonists | AVPR2, AVPR1B, AVPR1A | TERT 3790/4885ALDH1A1 1410/4885LMNA 2291/4885 |
| US-20140024640-A1 | Benzazepine Derivatives Useful as Vasopressin Antagonists | AVPR2, AVPR1B, AVPR1A | TERT 3790/4885ALDH1A1 1410/4885LMNA 2291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.